Advertisement

CRISPR Approach To Fighting Cancer Called 'Promising' In 1st Safety Test

The preliminary results described Wednesday come from two patients with multiple myeloma and one with sarcoma. This was just a first safety test, the scientists say, and was not designed to measure whether such a treatment would work. (EyeEm/Getty Images)
The preliminary results described Wednesday come from two patients with multiple myeloma and one with sarcoma. This was just a first safety test, the scientists say, and was not designed to measure whether such a treatment would work. (EyeEm/Getty Images)

Related:

Advertisement

More from WBUR

Listen Live
Close